Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
Sponsor: University of California, Davis
Summary
This pilot study is to determine whether it would be safe and feasible to inject CD34+ stem cells from bone marrow into the eye as treatment for patients who are irreversibly blind from various retinal conditions.
Official title: A Pilot Clinical Trial of the Feasibility and Safety of Intravitreal Autologous Adult Bone Marrow Stem Cells in Treating Eyes With Vision Loss From Retinopathy
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2012-07
Completion Date
2026-10
Last Updated
2026-01-29
Healthy Volunteers
No
Conditions
Interventions
CD34+ bone marrow stem cells intravitreal
Locations (1)
University of California Davis
Sacramento, California, United States